Roth MKM raised the firm’s price target on Aspen Aerogels to $36 from $28 and keeps a Buy rating on the shares. The firm is positive on the continued PyroThin momentum for the company, stating that it favors the current positioning for the company, including a clear focus on profitable growth, as the management positions the portfolio for what it sees as a “strong secular opportunity”, the analyst tells investors in a research note. 2024 represents a key inflection point, with Aspen Aerogels poised to demonstrate positive net income and significant growth for its thermal barriers, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels management to meet with Oppenheimer
- Aspen Aerogels price target raised to $36 from $30 at TD Cowen
- Aspen Aerogels price target raised to $36 from $30 at Piper Sandler
- Aspen Aerogels price target raised to $30 from $29 at Piper Sandler
- Aspen Aerogels call volume above normal and directionally bullish